BioSpace News Archive

Synthetic Biologics, Inc. announced receipt, on June 28, 2019, of notification from the NYSE American LLC that the Company has regained compliance with Part 10, Section 1003 of the NYSE American’s Company Guide relating to the Exchange’s continued listing requirements.

Apruve released the 2019 Medical Distributor Apruval Rating report, ranking the top businesses in the industry by their B2B eCommerce performance.

Seventh Sense Biosystems, Inc., makers of TAP™, the world’s first push-button blood collection device, and Miraca Holdings Inc.

Biogen (Nasdaq: BIIB) today announced new results from the NURTURE study, adding data to the longest study of spinal muscular atrophy (SMA) in pre-symptomatic infants (n=25)

ActoBio Therapeutics, Inc., a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON) and innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents, has announced that it will progress to the next stage of the Phase Ib/IIa clinical trial for investigational drug AG019 for the treatment of early-onset type 1 diabetes (T1D)

Agreement signed for South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Malawi, Kenya, Uganda

Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced that the Company will join the broad-market Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1.

Mallinckrodt plc, a global biopharmaceutical company, announced that it will report second quarter 2019 earnings results for the period ending June 28, 2019 on Tuesday, Aug. 6, 2019.

Merck’s supply chain and eCommerce strength will allow broader availability and accessibility of the Fire Monkey / Fire Flower product to customers

South Jersey Residents to Receive Greater Access to Care through Coordinated, Complementary Services